DK0839149T3 - Galanthamin-derivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler og farmaceutiske præparater omfattende dem - Google Patents
Galanthamin-derivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler og farmaceutiske præparater omfattende demInfo
- Publication number
- DK0839149T3 DK0839149T3 DK96926431T DK96926431T DK0839149T3 DK 0839149 T3 DK0839149 T3 DK 0839149T3 DK 96926431 T DK96926431 T DK 96926431T DK 96926431 T DK96926431 T DK 96926431T DK 0839149 T3 DK0839149 T3 DK 0839149T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical compositions
- pct
- pharmaceuticals
- preparation
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9514821.9A GB9514821D0 (en) | 1995-07-19 | 1995-07-19 | Galanthamine derivatives |
PCT/FR1996/001139 WO1997003987A1 (fr) | 1995-07-19 | 1996-07-19 | Nouveaux derives de la galanthamine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0839149T3 true DK0839149T3 (da) | 2004-08-09 |
Family
ID=10777948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96926431T DK0839149T3 (da) | 1995-07-19 | 1996-07-19 | Galanthamin-derivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler og farmaceutiske præparater omfattende dem |
Country Status (16)
Country | Link |
---|---|
US (1) | US5958903A (da) |
EP (1) | EP0839149B9 (da) |
JP (1) | JP4177894B2 (da) |
AT (1) | ATE264332T1 (da) |
AU (1) | AU6662396A (da) |
CA (1) | CA2227235C (da) |
DE (1) | DE69632194T2 (da) |
DK (1) | DK0839149T3 (da) |
ES (1) | ES2218596T3 (da) |
GB (1) | GB9514821D0 (da) |
IL (1) | IL122739A0 (da) |
MX (1) | MX9800407A (da) |
NO (1) | NO980215L (da) |
PT (1) | PT839149E (da) |
WO (1) | WO1997003987A1 (da) |
ZA (1) | ZA966163B (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1891954A3 (en) * | 1998-09-30 | 2009-01-14 | Takeda Pharmaceutical Company Limited | Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder |
AU1738800A (en) * | 1998-11-23 | 2000-06-13 | Bonnie Davis | Dosage formulations for acetylcholinesterase inhibitors |
HUP0104778A3 (en) | 1998-12-24 | 2004-05-28 | Janssen Pharmaceutica Nv | Controlled release galantamine composition |
US8603546B2 (en) * | 1999-01-11 | 2013-12-10 | Herbaceuticals Inc. | Herbal supplement for increased muscle strength and endurance for athletes |
US6159476A (en) * | 1999-01-11 | 2000-12-12 | Herbaceuticals | Herbal supplement for increased muscle strength and endurance for athletes |
DE69913138T2 (de) * | 1999-03-31 | 2004-08-26 | Eisai Co., Ltd. | Stabilisierte zusammensetzung mit nootropen wirkstoffen |
CA2368966A1 (en) * | 2000-03-31 | 2001-10-11 | Sanochemia Pharmazeutika Aktiengesellschaft | New derivatives and analogues of galanthamine |
DE10129265A1 (de) * | 2001-06-18 | 2003-01-02 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie |
JP4721386B2 (ja) * | 2001-07-10 | 2011-07-13 | 第一三共株式会社 | 新規ガランタミン類縁体 |
DE10134038A1 (de) * | 2001-07-12 | 2003-02-06 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit |
EP1681291A1 (de) * | 2002-03-25 | 2006-07-19 | Sanochemia Pharmazeutika Aktiengesellschaft | Verfahren zur Herstellung von Norgalanthamin, Ihren Isomeren, Salzen und Hydraten |
WO2005030332A2 (de) * | 2003-09-29 | 2005-04-07 | Sanochemia Pharmazeutika Ag | Verwendung von galanthamin und seinen derivaten zum herstellen von arzneimitteln |
AT414125B (de) * | 2003-09-29 | 2006-09-15 | Sanochemia Pharmazeutika Ag | Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln |
WO2005065662A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Solid dosage formulations of galantamine |
US20050191349A1 (en) * | 2003-12-31 | 2005-09-01 | Garth Boehm | Galantamine formulations |
DK1895994T3 (da) * | 2005-05-13 | 2010-12-20 | Alza Corp | Multilagsmedikamentleveringssystem med barriere mod reservoirmaterialeflow |
US20070104771A1 (en) * | 2005-09-23 | 2007-05-10 | Jay Audett | Transdermal galantamine delivery system |
AU2009290396B2 (en) * | 2008-09-11 | 2014-11-06 | I.B.R. Israeli Biotechnology Research Ltd. | Leucojum bulb extracts and use thereof |
US20120129838A1 (en) * | 2009-04-24 | 2012-05-24 | The Industry & Academic Cooperation In Chungnam National University | Composition for Preventing and Treating Alopecia Disorder Containing Morgalanthamine Compounds as an Active Ingredient |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4663318A (en) * | 1986-01-15 | 1987-05-05 | Bonnie Davis | Method of treating Alzheimer's disease |
US4735169A (en) * | 1986-09-03 | 1988-04-05 | Nordson Corporation | Adhesive applicator assembly |
KR100195399B1 (ko) * | 1987-05-04 | 1999-06-15 | 보니데이비스 | 알쯔하이머 병 치료용 의약 |
US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
US6323195B1 (en) * | 1993-10-15 | 2001-11-27 | Aventis Pharmaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
US5428159A (en) * | 1994-04-08 | 1995-06-27 | Ciba-Geigy Corporation | Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine |
-
1995
- 1995-07-19 GB GBGB9514821.9A patent/GB9514821D0/en active Pending
-
1996
- 1996-07-19 AU AU66623/96A patent/AU6662396A/en not_active Abandoned
- 1996-07-19 ZA ZA9606163A patent/ZA966163B/xx unknown
- 1996-07-19 PT PT96926431T patent/PT839149E/pt unknown
- 1996-07-19 DE DE69632194T patent/DE69632194T2/de not_active Expired - Lifetime
- 1996-07-19 DK DK96926431T patent/DK0839149T3/da active
- 1996-07-19 MX MX9800407A patent/MX9800407A/es unknown
- 1996-07-19 US US08/983,309 patent/US5958903A/en not_active Expired - Lifetime
- 1996-07-19 IL IL12273996A patent/IL122739A0/xx unknown
- 1996-07-19 CA CA2227235A patent/CA2227235C/fr not_active Expired - Fee Related
- 1996-07-19 ES ES96926431T patent/ES2218596T3/es not_active Expired - Lifetime
- 1996-07-19 AT AT96926431T patent/ATE264332T1/de active
- 1996-07-19 WO PCT/FR1996/001139 patent/WO1997003987A1/fr active IP Right Grant
- 1996-07-19 JP JP50637297A patent/JP4177894B2/ja not_active Expired - Fee Related
- 1996-07-19 EP EP96926431A patent/EP0839149B9/fr not_active Expired - Lifetime
-
1998
- 1998-01-16 NO NO980215A patent/NO980215L/no unknown
Also Published As
Publication number | Publication date |
---|---|
MX9800407A (es) | 1998-04-30 |
EP0839149B9 (fr) | 2005-03-09 |
DE69632194T2 (de) | 2005-03-17 |
ZA966163B (en) | 1997-02-10 |
NO980215D0 (no) | 1998-01-16 |
PT839149E (pt) | 2004-08-31 |
ATE264332T1 (de) | 2004-04-15 |
JP4177894B2 (ja) | 2008-11-05 |
GB9514821D0 (en) | 1995-09-20 |
CA2227235A1 (fr) | 1997-02-06 |
WO1997003987A1 (fr) | 1997-02-06 |
EP0839149A1 (fr) | 1998-05-06 |
JPH11509541A (ja) | 1999-08-24 |
CA2227235C (fr) | 2010-08-31 |
EP0839149B1 (fr) | 2004-04-14 |
ES2218596T3 (es) | 2004-11-16 |
NO980215L (no) | 1998-01-16 |
AU6662396A (en) | 1997-02-18 |
IL122739A0 (en) | 1998-08-16 |
US5958903A (en) | 1999-09-28 |
DE69632194D1 (de) | 2004-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0839149T3 (da) | Galanthamin-derivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler og farmaceutiske præparater omfattende dem | |
ZA973647B (en) | Inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them. | |
DK0477049T3 (da) | 3-amido-pyrazolderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem | |
HUP0001285A3 (en) | Pyrrolidine derivatives as protease inhibitors, process for producing them and pharmaceutical compositions containing them | |
SG64372A1 (en) | Rapamycin derivatives | |
PL314188A1 (en) | Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions | |
NO20002787L (no) | Nye forbindelser | |
NO975987D0 (no) | 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater | |
HUT70544A (en) | Heteroaryl-amines as acetyl-cholinesterase inhibitors, pharmaceutical compositions comprising them and process for their preparation | |
DK0506539T3 (da) | heterocykliske alkylamider, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
AU6617596A (en) | Cyclo-oxygenase inhibitor and amidine derivative salts, their preparation process, their use as medicaments, and pharmaceutical compositions containing them | |
HUP9602635A2 (en) | 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0002921A3 (en) | Cyanoguanidines as cell proliferation inhibitors, process for producing them and pharmaceutical compositions containing them | |
MX9708394A (es) | Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion. | |
HUP9601062A3 (en) | Chromone derivatives, pharmaceutical compositions containing them and process for their preparation | |
NO955320D0 (no) | Substituerte 4-fenyltiazolderivater, fremgangsmåte for fremstilling derav og farmasöytiske blandinger som inneholder dem | |
NO995685D0 (no) | Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasöytiske blandinger | |
NO20003290L (no) | N-fenylamid- og N-pyridylamidderivater, fremgangsmÕte for fremstilling av dem, og farmasøytiske preparater som inneholder dem | |
NO20006547L (no) | Salter av paroxetine | |
NO20014803D0 (no) | Pyrido-tieno-diazepiner, fremgangsmåte for fremstilling derav og farmasöytiske blandinger inneholdende dem | |
HUP9600173A3 (en) | 4-amino-benzoyl-guanidine derivatives, process for preparing them and pharmaceutical compositions containing them | |
DK0806949T3 (da) | Ny farmaceutisk komposition, der indeholder trimebutin, og fremgangsmåde til fremstilling deraf | |
DK0809627T3 (da) | Hidtil ukendte borneolderivater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse | |
DK0794184T3 (da) | 6-Methoxy-1H-benzotriazol-5-carboxamidderivater, fremgangsmåde til fremstilling deraf og lægemidler indeholdende dem | |
NO952715D0 (no) | Substituerte 1-(7-klor-4-kinoleinyl)pyrazol-3-karboksamid-N-oksyd-derivater, fremgangsmåte ved fremstilling derav og farmasöytiske preparater som inneholder dem |